Phase 1/2 A Multicenter, Controlled, Randomized, Open-Label, Dose Escalation, Safety. Tolerability and Pharmocokinetic Study Comparing EG-1962 and Nimodipine in Patients with Aneurysmal Subarachnoid Hemorrhage.
Clinical Trial Grant
Administered By
Neurology, Neurocritical Care
Awarded By
Edge Therapeutics, Inc
Start Date
November 1, 2013
End Date
May 31, 2016
Administered By
Neurology, Neurocritical Care
Awarded By
Edge Therapeutics, Inc
Start Date
November 1, 2013
End Date
May 31, 2016